Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Masters

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Intraoperative sentinel lymph node mapping in non-small-cell lung cancer improves detection of micrometastasesMichael J Liptay, Sean C Grondin, Willard A Fry, et al.
American Journal of Clinical Oncology|December 16, 2014
Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies: HOG LUN 07-130Shadia I Jalal, Nasser Hanna, Robin Zon, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2002
Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I studyPhilip C Hoffman, Ezra E W Cohen, Gregory A Masters, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancerGregory A Masters, Athanassios E Argiris, Elizabeth A Hahn, et al.
Lung Cancer (Amsterdam, Netherlands)|April 24, 2021
Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538Jeffrey A Bogart, Xiaofei Wang, Gregory A Masters, et al.
Cancer Medicine|June 16, 2018
Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non-small-cell lung cancerNicole F Laslett, SuJung Park, Gregory A Masters, et al.
JCO Oncology Practice|February 17, 2026
Barriers to the Adoption of Healthy Lifestyle Behaviors in Patients With Cancer: Results of a National SurveyRebekah L Wilson, Anita Giobbie-Hurder, Catherine M Bender, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2008
Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105Mark A Socinski, A William Blackstock, Jeffrey A Bogart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203Martin J Edelman, Dee Watson, Xiaofei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance)Neal E Ready, Herbert H Pang, Lin Gu, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Intraoperative sentinel lymph node mapping in non-small-cell lung cancer improves detection of micrometastasesMichael J Liptay, Sean C Grondin, Willard A Fry, et al.
American Journal of Clinical Oncology|December 16, 2014
Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies: HOG LUN 07-130Shadia I Jalal, Nasser Hanna, Robin Zon, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2002
Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I studyPhilip C Hoffman, Ezra E W Cohen, Gregory A Masters, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancerGregory A Masters, Athanassios E Argiris, Elizabeth A Hahn, et al.
Lung Cancer (Amsterdam, Netherlands)|April 24, 2021
Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538Jeffrey A Bogart, Xiaofei Wang, Gregory A Masters, et al.
Cancer Medicine|June 16, 2018
Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non-small-cell lung cancerNicole F Laslett, SuJung Park, Gregory A Masters, et al.
JCO Oncology Practice|February 17, 2026
Barriers to the Adoption of Healthy Lifestyle Behaviors in Patients With Cancer: Results of a National SurveyRebekah L Wilson, Anita Giobbie-Hurder, Catherine M Bender, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2008
Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105Mark A Socinski, A William Blackstock, Jeffrey A Bogart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203Martin J Edelman, Dee Watson, Xiaofei Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance)Neal E Ready, Herbert H Pang, Lin Gu, et al.
Pageof 5